THOMAS JAY RAIFE, MD
Medical Practice at Hawkins Dr, Iowa City, IA
License number
Iowa 29987
Category
Medical Practice
Type
Blood Banking & Transfusion Medicine
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 356-0369
(319) 356-0331 (Fax)
(319) 356-0331 (Fax)
Professional information
Thomas Jay Raife, Iowa City IA
Specialties:
Pathology, Blood Banking & Transfusion Medicine, Clinical Pathology/Laboratory Medicine, Clinical Pathology
Work:
University of Iowa
200 Hawkins Dr, Iowa City, IA 52243
200 Hawkins Dr, Iowa City, IA 52243
Education:
University of Iowa (1989)
Dr. Thomas J Raife, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Blood Banking & Transfusion Medicine
Address:
University/Iowa Hospital Pat
200 Hawkins Dr, Iowa City 52242
(319) 356-0369 (Phone)
200 Hawkins Dr, Iowa City 52242
(319) 356-0369 (Phone)
Certifications:
Blood Bank & Transfusion Medicine, 1997, Clinical Pathology, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University/Iowa Hospital Pat
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
University of Ia Roy J & L Carver Com
Graduated: 1989
University of Ia Roy J & L Carver Com
Graduated: 1989
Synthetic And Recombinant Substrates For The Detecion Of The Von Willebrand Factor-Cleaving Protease
US Patent:
2005015, Jul 14, 2005
Filed:
Jul 27, 2001
Appl. No.:
10/333506
Inventors:
Robert Montgomery - Cedarburg WI, US
Thomas Raife - Iowa City IA, US
Sandra Haberichter - Greenfield WI, US
Thomas Raife - Iowa City IA, US
Sandra Haberichter - Greenfield WI, US
International Classification:
C12Q001/37
US Classification:
435023000
Abstract:
A method of detecting von Willebrand Factor-cleaving protease in a test sample is disclosed. In one embodiment, the method comprises the steps of (a) obtaining a test bodily fluid sample; (b) exposing the test sample to a monomeric von Willebrand Factor fragment, wherein the fragment comprises amino acids 842 and 843, wherein cleavage of the fragment will occur proportional to the amount of protease in the sample; and (c) comparing the cleavage products to a standard curve and determining the amount of von Willebrand Factor-cleaving protease in the test sample.
Human Thrombomodulin In Wound Healing
US Patent:
5583102, Dec 10, 1996
Filed:
Dec 3, 1993
Appl. No.:
8/162462
Inventors:
Steven R. Lentz - Iowa City IA
Thomas J. Raife - Iowa City IA
Donna J. Lager - Iowa City IA
Thomas J. Raife - Iowa City IA
Donna J. Lager - Iowa City IA
Assignee:
University of Iowa Research Foundation - Oakdale IA
International Classification:
A61K 3816, A61K 3817, C07K 14435, C07K 1447
US Classification:
514 8
Abstract:
The use of human thrombomodulin and acceptable derivatives thereof as an agent for stimulating wound regeneration including epithilial cell differentiation is disclosed.